Projects funded by the NCN
The effects of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors on changes in selected epigenetic mechanisms and DNA damage in heterozygous familial hypercholesterolaemia
2022/45/N/NZ7/01622
Keywords:
PCSK9 inhibitors LDL cholesterol familial hypercholesterolaemia oxidative DNA damage epigenetic changes DNA methylation histone modifications oxidative stress lipid peroxidation
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Medyczny w Łodzi, Wydział Lekarski
woj. łódzkie
Principal investigator (from the host institution):
Number of co-investigators in the project: 2
Call: PRELUDIUM 21 - announced on 2022-03-28
Amount awarded: 208 766 PLN
Project start date (Y-m-d): 2023-03-01
Project end date (Y-m-d): 2026-02-28
Project duration:: 36 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.